Invetech Discover how automation of tailored vaccine processing can lead to commercial success

Released on: June 3, 2008, 2:53 am

Press Release Author: The Scott Partnership

Industry:

Press Release Summary: A presentation by Invetech at BioProcess Theater, at the Bio
International Conference 2008

Press Release Body: Discover how automation of tailored vaccine processing can lead
to commercial success

A presentation by Invetech at BioProcess Theater, at the Bio International
Conference 2008

(Melbourne, Australia - 2 June 2008) Invetech, specialists in product development
and custom automation for the medical, industrial and consumer markets, presents
\"Automated Tailored Vaccine Process\" at the upcoming BioProcess Theater during the
2008 Bio International Convention, June 17-20, San Diego convention Center, San
Diego, CA. The presentation will take place on Wednesday 18 June, 2008 at 11.00am.

As leaders in delivery of integrated platforms and process designs in the
pharmaceutical and biotechnology industries, Invetech will present a methodology
used to assess the technical and commercial drivers that resulted in the automation
of a single patient therapeutic processing system.

\"Our business is to translate client processes developed by the scientific community
into robust systems for successful commercialization. We believe conference
delegates will benefit from our experience in characterizing Cellular Therapeutic
Process automation\" said presenter Ian Fitzpatrick, Manager of Manufacturing
Innovation, Invetech.

\"Delegates will be able to relate our practical examples to their own developments
in this area. They will learn product quality and batch record management are
principal drivers of automation investment. In addition we will show how novel
process steps can confidently be addressed with purpose designed devices and
equipment by the application of the \"quality by design methodology\", says
Fitzpatrick.

The presentation includes a case study, which discusses the process of evaluating
and selecting novel unit processes that resulted in the use of single-use devices.
Invetech will demonstrate the opportunities this technology creates while addressing
clinical process needs and affordability.

Invetech develops custom automation systems, devices, instruments, and consumables
for companies across the world. With over 30 years\' experience in product and
systems development, Invetech partners with a wide range of clients from leading
brands to young start-ups to navigate product development and manufacturing systems
development challenges to deliver reliable, quality results for our clients
dedicated markets.

The company\'s extensive experience covers a wide range of sectors including;
diagnostics, medical devices, life sciences, bioprocessing and drug discovery. With
a proven track record of hundreds of development projects worldwide, Invetech\'s
services are increasingly relied upon by industry experts seeking an experienced
outsourcing co-development partner.

For more information about Invetech\'s innovative instrument development and custom
automation services, please contact Invetech on information@invetech.us, visit the
website www.invetech.us, or phone East Coast US: +1 203 675 4502, West Coast US: +1
415 533 1958.

- ENDS -

For further press information please contact Fiona Robinson, The Scott Partnership,
1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone
+44 1477 539539, Fax +44 1477 539540, Email Invetech@scottpr.co.uk

Invetech Pty Ltd, 495 Blackburn Road, Mt Waverley Vic 3149, Australia. Phone
+613 9211 7713, Fax +613 9211 7703. Email: rmb@invetech.com.au Web:
www.invetech.com.au

About Invetech\'s Instrumentation and Custom Automation services:
For more than 30 years Invetech has been at the forefront of new product development
and custom automation. With experience drawn from over 5,000 projects, Invetech
delivers global contract design and development, contract instrument manufacturing
and custom automation services to a range of market sectors including FMCG,
Cleantech, life sciences, drug discovery and pharmaceutical companies, in addition
to 7 of the world\'s top 10 clinical diagnostic companies.

Invetech combines its integrated in-house capabilities, specialist knowledge and
diverse experience to deliver better solutions, in the shortest possible time and
with less risk, to its client base of start-ups through to multinationals. Its
commercial focus, responsive and flexible approach, and unbiased solutions, means
clients get the best outcome with the aim of commercial success.



Web Site: http://

Contact Details: Fiona Robinson, The Scott Partnership, 1 Whiteside, Station Road,
Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, Fax +44 1477
539540, Email Invetech@scottpr.co.uk

Invetech Pty Ltd, 495 Blackburn Road, Mt Waverley Vic 3149, Australia. Phone
+613 9211 7713, Fax +613 9211 7703. Email: rmb@invetech.com.au Web:
www.invetech.com.au

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •